Benzinga | Aug 6, 2020 04:13PM EDT

Xenon Pharmaceuticals Q2 Sales $13.38M Beat $6.90M Estimate

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly sales of $13.38 million which beat the analyst consensus estimate of $6.90 million by 93.97 percent.